Annals of Thoracic Medicine Official publication of the Saudi Thoracic Society, affiliated to King Saud University
Search Ahead of print Current Issue Archives Instructions Subscribe e-Alerts Login 
Home Email this article link Print this article Bookmark this page Decrease font size Default font size Increase font size

    Article Cited by others


Idiopathic pulmonary fibrosis in Saudi Arabia: Demographic, clinical, and survival data from two tertiary care hospitals

Sherbini Nahid, Feteih Maun N, Wali Siraj O, Alamoudi Omer S, Al-Faifi Salem M, Khalid Imran

Year : 2014| Volume: 9| Issue : 3 | Page no: 168-172

   This article has been cited by
1 Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review
Yet H. Khor, Yvonne Ng, Hayley Barnes, Nicole S.L. Goh, Christine F. McDonald, Anne E. Holland
European Respiratory Review. 2020; 29(157): 190158
[Pubmed]  [Google Scholar] [DOI]
2 A preliminary study: MUC5B promoter polymorphism and its association with IPF
Hoda Ali Abu Yusuf, Mohamed Galal, Safy Kaddah, Marwa el Sharkawy, Mohamed Shaaban Mousa, Heba Moussa
The Egyptian Journal of Bronchology. 2020; 14(1)
[Pubmed]  [Google Scholar] [DOI]
3 Diabetes Mellitus Contributes to Idiopathic Pulmonary Fibrosis: A Review From Clinical Appearance to Possible Pathogenesis
Dongguang Wang, Yao Ma, Xiang Tong, Yonggang Zhang, Hong Fan
Frontiers in Public Health. 2020; 8
[Pubmed]  [Google Scholar] [DOI]
4 Comorbid Metabolic Disorders in Chronic Lung Diseases
M.I. Gumeniuk
Infusion & Chemotherapy. 2019; (3): 5
[Pubmed]  [Google Scholar] [DOI]
5 Lifestyle associated diseases and risk of pulmonary hypertension in patients with idiopathic pulmonary fibrosis
Safy Kaddah,Sabah Ahmed
Egyptian Journal of Chest Diseases and Tuberculosis. 2016; 65(1): 127
[Pubmed]  [Google Scholar] [DOI]


Read this article